연구성과로 돌아가기
JCR 2024 저널 목록 (1120 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia-Pacific Journal of Financial Studies | WILEY | 2041-9945 | 2041-6156 | SSCI | BUSINESS, FINANCE | 559 | 1.5 | Q3 | 57.1 | 42.9 | 138/241 | 1.8 | Q3 | 1.5 | 0.1 | 0.40 | 149/241 | Q3 | 38.38 | 0.000 | 0.090 | 0.337 | Q3 | 28 | 100.0% | 6.1 | 10.9 | 28 | 10.8% | 2025-08-05 16:02:35 | 바로가기 |
| CELL BIOLOGY INTERNATIONAL | WILEY | 1065-6995 | 1095-8355 | SCIE | CELL BIOLOGY | 6,594 | 3.1 | Q3 | 57.1 | 42.9 | 117/204 | 3.5 | Q3 | 3.0 | 0.6 | 0.47 | 148/204 | Q3 | 27.70 | 0.005 | 1.112 | 0.652 | Q3 | 134 | 81.3% | 5.8 | 6.7 | 109 | 10.4% | 2025-08-05 16:02:38 | 바로가기 |
| Frontiers in Bioscience-Landmark | IMR PRESS | 2768-6701 | 2768-6698 | SCIE | CELL BIOLOGY | 11,456 | 3.1 | Q3 | 57.1 | 42.9 | 117/204 | 3.2 | Q3 | 3.0 | 0.8 | 0.44 | 155/204 | Q4 | 24.26 | 0.005 | 1.140 | 0.622 | Q3 | 412 | 68.0% | 12.4 | 6.4 | 280 | 98.7% | 2025-08-05 16:02:38 | 바로가기 |
| Human Cell | SPRINGER JAPAN KK | 0914-7470 | 1749-0774 | SCIE | CELL BIOLOGY | 2,678 | 3.1 | Q3 | 57.1 | 42.9 | 117/204 | 3.1 | Q3 | 3.0 | 0.5 | 0.47 | 148/204 | Q3 | 27.70 | 0.003 | 0.767 | 0.618 | Q3 | 134 | 79.8% | 3.5 | 6.2 | 107 | 16.3% | 2025-08-05 16:02:38 | 바로가기 |
| International Finance | WILEY | 1367-0271 | 1468-2362 | SSCI | BUSINESS, FINANCE | 453 | 1.5 | Q3 | 57.1 | 42.9 | 138/241 | 1.4 | Q3 | 1.5 | 0.2 | 0.40 | 149/241 | Q3 | 38.38 | 0.000 | 0.070 | 0.379 | Q3 | 10 | 100.0% | 10.2 | 9.5 | 10 | 4.1% | 2025-08-05 16:02:35 | 바로가기 |
| International Journal of Central Banking | ASSOC INTERNATIONAL JOURNAL CENTRAL BANKING | 1815-4654 | 1815-7556 | SSCI | BUSINESS, FINANCE | 1,211 | 1.5 | Q3 | 57.1 | 42.9 | 138/241 | 1.7 | Q3 | 1.5 | 0.3 | 0.33 | 166/241 | Q3 | 31.33 | 0.002 | 0.446 | 1.239 | Q1 | 32 | 96.9% | 9.3 | 7.9 | 31 | 0.0% | 2025-08-05 16:02:35 | 바로가기 |
| IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE | CAMBRIDGE UNIV PRESS | 0790-9667 | 2051-6967 | ESCI | PSYCHIATRY | 959 | 2.1 | Q3 | 57.1 | 42.9 | 165/288 | 2.4 | Q3 | 1.8 | 0.5 | 0.78 | 122/288 | Q2 | 57.81 | 0.001 | 0.266 | 0.557 | Q3 | 42 | 90.5% | 4.3 | 5.5 | 38 | 31.5% | 2025-08-05 16:36:05 | 바로가기 |
| ISSUES IN ACCOUNTING EDUCATION | AMER ACCOUNTING ASSOC | 0739-3172 | 1558-7983 | ESCI | BUSINESS, FINANCE | 960 | 1.5 | Q3 | 57.1 | 42.9 | 138/241 | 2.0 | Q3 | 1.0 | 0.4 | 0.40 | 149/241 | Q3 | 38.38 | 0.000 | 0.082 | 0.311 | Q3 | 41 | 97.6% | 10.5 | 7.4 | 40 | 0.0% | 2025-08-05 16:02:35 | 바로가기 |
| Journal of Banking Regulation | PALGRAVE MACMILLAN LTD | 1745-6452 | 1750-2071 | ESCI | BUSINESS, FINANCE | 361 | 1.5 | Q3 | 57.1 | 42.9 | 138/241 | 1.4 | Q3 | 1.4 | 0.2 | 0.38 | 154/241 | Q3 | 36.31 | 0.000 | 0.075 | 0.277 | Q3 | 31 | 100.0% | 4.5 | 8.5 | 31 | 25.6% | 2025-08-05 16:02:35 | 바로가기 |
| JOURNAL OF ECONOMICS AND FINANCE | SPRINGERNATURE | 1055-0925 | 1938-9744 | ESCI | BUSINESS, FINANCE | 775 | 1.5 | Q3 | 57.1 | 42.9 | 138/241 | N/A | N/A | 1.4 | 0.3 | 0.51 | 126/241 | Q3 | 47.93 | 0.000 | 0.110 | N/A | N/A | 43 | 97.7% | 7.2 | 9.3 | 42 | 18.9% | 2025-08-05 16:02:35 | 바로가기 |
| JOURNAL OF LEUKOCYTE BIOLOGY | OXFORD UNIV PRESS | 0741-5400 | 1938-3673 | SCIE | CELL BIOLOGY | 18,133 | 3.1 | Q3 | 57.1 | 42.9 | 117/204 | 5.1 | Q2 | 2.9 | 0.5 | 0.67 | 104/204 | Q3 | 49.26 | 0.011 | 2.410 | 1.386 | Q2 | 237 | 84.4% | 10.9 | 8.0 | 200 | 24.0% | 2025-08-05 16:02:38 | 바로가기 |
| Journal of Revenue and Pricing Management | PALGRAVE MACMILLAN LTD | 1476-6930 | 1477-657X | ESCI | BUSINESS, FINANCE | 686 | 1.5 | Q3 | 57.1 | 42.9 | 138/241 | 1.4 | Q3 | 0.8 | 0.6 | 0.36 | 161/241 | Q3 | 33.40 | 0.000 | 0.094 | 0.215 | Q4 | 45 | 100.0% | 4.9 | 8.7 | 45 | 18.6% | 2025-08-05 16:02:35 | 바로가기 |
| PSYCHIATRY RESEARCH-NEUROIMAGING | ELSEVIER IRELAND LTD | 0925-4927 | 1872-7506 | SCIE | PSYCHIATRY | 5,237 | 2.1 | Q3 | 57.1 | 42.9 | 165/288 | 2.3 | Q3 | 2.0 | 0.2 | 0.60 | 183/288 | Q3 | 36.63 | 0.003 | 0.663 | 0.710 | Q3 | 95 | 93.7% | 10.3 | 9.5 | 89 | 19.1% | 2025-08-05 16:36:04 | 바로가기 |
| Research in Autism Spectrum Disorders | ELSEVIER SCI LTD | 1750-9467 | 1878-0237 | SSCI | PSYCHIATRY | 5,852 | 2.1 | Q3 | 57.1 | 42.9 | 165/288 | 3.3 | Q2 | 2.0 | 0.3 | 1.12 | 59/288 | Q1 | 79.69 | 0.004 | 0.981 | 0.921 | Q2 | 138 | 92.0% | 8.7 | 8.7 | 127 | 31.6% | 2025-08-05 16:36:04 | 바로가기 |
| Review of Asset Pricing Studies | OXFORD UNIV PRESS | 2045-9920 | 2045-9939 | ESCI | BUSINESS, FINANCE | 783 | 1.5 | Q3 | 57.1 | 42.9 | 138/241 | 5.2 | Q1 | 1.5 | 0.8 | 0.53 | 122/241 | Q3 | 49.59 | 0.004 | 0.858 | 4.646 | Q1 | 16 | 100.0% | 4.6 | 11.6 | 16 | 26.4% | 2025-08-05 16:02:35 | 바로가기 |
페이지 이동: